2022 and BioTech - Connected Health Pulse

Bonfire Analytics Raises Oversubscribed $2M Venture Round to Accelerate Digital Health, Medical Device, & Biotech Adoption Across Healthcare Providers

Healthcare IT Today

FEBRUARY 22, 2024

Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).

BioTech

BioTech Digital Health HIPAA Medicare

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

Health Populi

APRIL 26, 2022

The press release lists the names of each of the 47 individual pharma companies assessed, such as Big Pharma leaders like AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Merck, Novartis, and Pfizer, along with companies associated with biotech like Amgen, Biogen, Genentech, and Gilead. Generics such as Mylan and Teva, among others.

BioTech

BioTech Life Science Pharmaceuticals

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. And I propose a toast: “To stop talking about involving patients and actually do it in 2022. How do we get the patient to actually be the one improving patient experience?

BioTech

BioTech Life Science Drug Development Patient Experience

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

FEBRUARY 1, 2023

Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. After all of this time and energy expended, it’s only right that patients would be witness to accountability of pharma/biotech to incorporate our collective voice.

BioTech

BioTech Drug Development Meaningful Use Pharmaceuticals

BioscienceLA Launches Leadership Catalyst Program For Emerging Leaders in the Life Sciences

Digital Health Global

AUGUST 15, 2023

–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.

Life Science

Life Science Leadership BioTech Digital Health

Wyss Center Geneva Appoints Erwin Böttinger as new Chief Executive Officer

Digital Health Global

APRIL 3, 2023

Together with our partners from the École Polytechnique Fédérale de Lausanne, the University of Geneva and Geneva University Hospital, the Wyss Center is poised to catalyze the unique concentration of world-class brain health research at Campus Biotech to drive clinical breakthroughs.”

BioTech

BioTech Life Science Mental health Digital Health

Bonfire Analytics, an AI-Driven Sales Intelligence Platform, Closes Pre-Seed Round

Healthcare IT Today

SEPTEMBER 18, 2023

The company was recently founded in 2022 and has achieved tangible success for both itself and its clients. Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics.

BioTech

BioTech Digital Health Health IT Healthcare IT

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

MAY 20, 2021

health citizens’ memories will last into 2022 with respect to cross-party desire for the U.S. The one segment which has stayed relatively even from 2018 has been biotech, 55% that year and 55% again in 2021. to approve Medicare’s negotiation of drug prices with pharmaceutical companies]. On these factors, the U.S.

BioTech

BioTech Pharmaceuticals Leadership Medicare

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

MAY 4, 2023

First, we look at the macro picture on health services utilization comparing the end of 2022 with pre-COVID-19 levels. The second graph portrays the same data in greater granularity, illustrating the variability of the four service areas over time comparing Q2 2020 with Q4 2022.

Public Health

Public Health Mental health Life Science Telehealth

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Digital Health Global

DECEMBER 5, 2023

This infusion of capital, supported by new investor Bpifrance (through its InnoBio 2 fund), and existing backers Khosla Ventures and Seventure Partners (with Health For Life Capital ), propels Eligo towards becoming a clinical-stage biotech. Concurrent with this financing, Laia Crespo, Ph.D., Partner at Sanofi Ventures.

Life Science

Life Science BioTech Digital Health

Bonus Features – November 20, 2022 – 90% of healthcare buyers prioritize virtual care but want a clear roadmap, wearable data helped predict COVID-19 infections 12 days before the CDC, and more

Healthcare IT Today

NOVEMBER 20, 2022

The Biotech Breakthrough Awards Program announced its 2022 award winners. The South Dakota Department of Health selected Avel eCare to connect EMS agencies in the state to emergency physicians and registered nurses via telemedicine. LabCorp opted for Oracle Cerner to manage its hospital-based laboratories in 10 states.

eCare

eCare BioTech Primary Care Life Science

Bonus Features – May 7, 2023 – Less than 1% of all medical claims include an ICD-10 Z code, 78% of consumers say virtual health is important when considering health plans, and more

Healthcare IT Today

MAY 7, 2023

News CMS has opened the Hardship Exception application period for eligible hospitals and critical access hospitals (CAHs) that participated in the Medicare Promoting Interoperability Program in 2022. Global venture capital funding was just $21 billion in April 2023 , a 56% drop from April 2022, according to Crunchbase.

RCM

RCM EHR Mental health BioTech

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

Digital Health Global

APRIL 5, 2024

Cue Health Targets DTC Market in 2022 6.17 ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 6 OTC/DTC Infectious Disease Testing Recent Developments 6.1 Recent Developments – Importance and How to Use This Section 6.1.1 Importance of These Developments 6.1.2 for TB, HPV Tests 6.4

BioTech

BioTech Digital Health Medicare Telehealth

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

FEBRUARY 13, 2024

Source: [link] Scotland's top ten tech start-ups - HealthTech related companies Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. At the top is Glasgow-based Amphista Therapeutics, which raised $50m in 2022.

Healthcare Innovation

Healthcare Innovation Digital Health Life Science healthcare technology

HealthTech Scotland Primed for Success: 80% of Scotland's Top Ten Start-ups are HealthTech related

Lloyd Price

SEPTEMBER 16, 2023

Exec Summary: Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. The company raised $10m in 2022. This represents a year-on-year increase of 12%. Resolution Therapeutics is a spin-out of the University of Edinburgh.

Life Science

Life Science Digital Health BioTech Health Technology

Aptar Appoints Julie Xing to its Board of Directors

Digital Health Global

MARCH 1, 2023

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Since 2022, Julie has served as Executive Chair of the Board of Directors of Mundipharma China.

Pharmaceuticals

Pharmaceuticals Leadership BioTech Digital Health

Third Culture Capital Leads Latest Funding Round for Ciba Health

Digital Health Global

FEBRUARY 7, 2023

31, 2022 at an undisclosed amount. 3CC prioritizes early-stage investments in “Third Culture entrepreneurs” whose unique perspectives have the potential to help transform healthcare and address health disparities by optimizing care delivery in healthtech and biotech. The funding round led by 3CC closed on Dec.

Chronic pain management

Chronic pain management BioTech Pain management Healthcare Innovation

Mark Cuban Cost Plus Drug Company and OncoPower Team Up to Bring Medication Adherence and Cost Savings to Cancer Patients

Digital Health Global

JANUARY 30, 2023

The costplusdrugs.com online pharmacy launched in January 2022 now carries over 1,000 prescription products, delivered by mail to thousands of happy customers every day. Collaboration focuses on pricing transparency, affordable access, and engaging patients at home to ensure treatment adherence.

BioTech

BioTech Pharmaceuticals Digital Health Public Health

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Digital Health Global

SEPTEMBER 27, 2023

Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds. ClavystBio was conceived and launched by Temasek to be a venture builder, trusted partner, and keystone to catalyze global health solutions from Singapore.

Life Science

Life Science Drug Development HC BioTech

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science

Life Science Digital Health EHR BioTech

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

JUNE 20, 2023

Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. has been a senior executive/CEO, as well as a chairman, board member, and entrepreneur in multiple public and private biotech and pharma companies in the U.S. Jane Rhodes, Ph.D.,

BioTech

BioTech Life Science Leadership Drug Development

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

AUGUST 30, 2023

QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. percent in 2022, the lowest the industry has seen in decades,” said Orr Inbar, CEO and Co-Founder of QuantHealth. “We

BioTech

BioTech Drug Development Life Science Pharmaceuticals

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Digital Health Global

MAY 8, 2023

BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades.

Pharmaceuticals

Pharmaceuticals Life Science BioTech Leadership

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. CAGR 2022-2032) market.

Life Science

Life Science Digital Health Drug Development Patient Experience

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Healthcare IT Today

NOVEMBER 7, 2023

billion in 2022, with an average 7.1-year “This investment provides us with the resources to further advance our platform and expand our reach to additional pharma, CRO, and biotech companies in Europe and the U.S., A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 year deployment time.

Drug Development

Drug Development BioTech Pharmaceuticals Health IT

The intersection of remote patient monitoring and AI

Healthcare IT News - Telehealth

OCTOBER 25, 2022

She has been involved with more than 20 early-stage biotech and healthcare startups, including ones working on medical devices and digital health. In 2022, CMS launched CPT codes for remote therapeutic monitoring (RTM). Robin Farmanfarmaian is a Silicon Valley-based entrepreneur working in technology and artificial intelligence.

BioTech

BioTech EHR Medicare Interoperability

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

FEBRUARY 22, 2021

consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Even more health citizens will expect this kind of health industry engagement in our second year of COVID (call it the Year of Vaccines) and beyond into 2022. Why was this the case? Osterholm has called it.

Life Science

Life Science Pharmaceuticals Public Health BioTech

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

AUGUST 16, 2021

health consumers, prescribers, and pharma manufacturers wait on regulation and policy to sort out health politics between now and the 2022 mid-term elections, the private sector (and State Medicaid programs) move at their will and make decisions based on current market conditions and certainties.

Pharmaceuticals

Pharmaceuticals Telehealth BioTech Mental health

Connected Health Pulse

Bonfire Analytics Raises Oversubscribed $2M Venture Round to Accelerate Digital Health, Medical Device, & Biotech Adoption Across Healthcare Providers

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

Trending Sources

Let’s Save the Date and Make Patient Engagement Official in 2022

Patients and Industry: Starting Our New Life Together in 2023

BioscienceLA Launches Leadership Catalyst Program For Emerging Leaders in the Life Sciences

Wyss Center Geneva Appoints Erwin Böttinger as new Chief Executive Officer

Bonfire Analytics, an AI-Driven Sales Intelligence Platform, Closes Pre-Seed Round

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Bonus Features – November 20, 2022 – 90% of healthcare buyers prioritize virtual care but want a clear roadmap, wearable data helped predict COVID-19 infections 12 days before the CDC, and more

Bonus Features – May 7, 2023 – Less than 1% of all medical claims include an ICD-10 Z code, 78% of consumers say virtual health is important when considering health plans, and more

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

HealthTech Scotland Primed for Success: 80% of Scotland's Top Ten Start-ups are HealthTech related

Aptar Appoints Julie Xing to its Board of Directors

Third Culture Capital Leads Latest Funding Round for Ciba Health

Mark Cuban Cost Plus Drug Company and OncoPower Team Up to Bring Medication Adherence and Cost Savings to Cancer Patients

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Emerging trends in the European HealthTech M&A market 2023

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

The intersection of remote patient monitoring and AI

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Stay Connected